Prevalence and Factors Associated With Atrial Fibrillation in Patients With Type 2 Diabetes

Completed

• Conditions: Atrial Fibrillation; Type 2 Diabetes
• Interventions: Other: Routine examinations

• Registration Number: NCT06174129
• Lead Sponsor: Burapha University

Brief Summary

This case-control study was conducted at Burapha University Hospital. The 12-lead electrocardiography recordings of type 2 diabetes patients were reviewed by a cardiologist to confirm the presence of atrial fibrillation. The clinical parameters, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications were analyzed and compared between atrial fibrillation and non-atrial fibrillation patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-06-01
• Primary Completion: 2023-06-30
• Study Completion: 2023-07-31
• Status Verified: 2023-12
• Study First Submitted: 2023-12-08
• Study First Submitted QC: 2023-12-08
• Last Update Submitted: 2023-12-08
• Study First Posted: 2023-12-18
• Last Update Posted: 2023-12-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 427

Inclusion Criteria

• Outpatients with type 2 diabetes who visited the medical clinic between June 2022 and June 2023

Exclusion Criteria

• Patients with missing information on the urinary albumin value and electrocardiograms at the latest date

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Type 2 diabetes patients with atrial fibrillation	Routine examinations	The 12-lead electrocardiography recordings of type 2 diabetes patients were reviewed by a cardiologist to confirm the presence of atrial fibrillation. The clinical parameters, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications were analyzed and compared between atrial fibrillation and non-atrial fibrillation patients.
Type 2 diabetes patients without atrial fibrillation	Routine examinations	The 12-lead electrocardiography recordings of type 2 diabetes patients were reviewed by a cardiologist to confirm the presence of atrial fibrillation. The clinical parameters, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications were analyzed and compared between atrial fibrillation and non-atrial fibrillation patients.

Primary Outcome Measures

Name	Time	Method
Prevalence of atrial fibrillation	June 2022 and June 2023	Prevalence of atrial fibrillation in patients with type 2 diabetes
Factors associated with atrial fibrillation	June 2022 and June 2023	Factors associated with atrial fibrillation in patients with type 2 diabetes, including age, hypertension, heart failure, thyroid disease, type 2 diabetes duration, body mass index, estimated glomerular filtration rate, glycated hemoglobin, presence of albuminuria, and use of diuretic medications

Trial Locations

Locations (1)

Burapha University Hospital; 🇹🇭 Mueang, Chonburi, Thailand